Intramuscular testosterone undecanoate for substitution in male hypogonadism - longterm treatment of 13.5 years: Metabolic efficacy and safety

被引:0
|
作者
Zitzmann, M. [1 ]
Saad, F. [2 ]
Nieschlag, E. [1 ]
Kliesch, S. [1 ]
机构
[1] Univ Clin, Dept Clin Androl, Munster, Germany
[2] Gulf Med Univ, Dept Med, Ajman, U Arab Emirates
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E592 / U270
页数:2
相关论文
共 50 条
  • [21] TREATMENT OF MALE HYPOGONADISM WITH INJECTABLE TESTOSTERONE UNDECANOATE: OUTCOME META-ANALYSIS STUDY
    Corona, G.
    Maseroli, E.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 12 - 12
  • [22] Intramuscular testosterone undecanoate:: Pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism
    Schubert, M
    Minnemann, T
    Hübler, D
    Rouskova, D
    Christoph, A
    Oettel, M
    Ernst, M
    Mellinger, U
    Krone, W
    Jockenhövel, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5429 - 5434
  • [23] EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM
    Cunningham, Glenn
    Belkoff, Laurence
    Brock, Gerald
    Efros, Mitchell
    Gittelman, Marc
    Carrara, Dario
    Neijber, Anders
    Ando, Masakazu
    Mitchel, Jules
    ENDOCRINE PRACTICE, 2017, 23 (05) : 557 - 565
  • [24] Clinical efficacy of the long-acting intramuscular compared to oral testosterone undecanoate in adult men with central hypogonadism
    Gheorghiu, Monica Livia
    Badiu, C.
    Caragheorgheopo, Andra
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2008, 4 (01) : 59 - 73
  • [25] LONG-ACTING INTRAMUSCULAR TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF 118 LATE-ONSET HYPOGONADISM IN MALES
    Permpongkosol, Sompol
    Talubsri, Pungrudee
    JOURNAL OF UROLOGY, 2009, 181 (04): : 489 - 489
  • [26] Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals
    Jacobeit, Jens W.
    Gooren, Louis J.
    Schulte, Heinrich M.
    JOURNAL OF SEXUAL MEDICINE, 2007, 4 (05): : 1479 - 1484
  • [27] Metabolic Changes in Gender Dysphoria FTM Subjects During Treatment with Intramuscular Testosterone Undecanoate Injections
    Hughes, Jeanette Wahlberg
    INTERNATIONAL JOURNAL OF SEXUAL HEALTH, 2019, 31 : A225 - A226
  • [28] Longterm experience of up to 8.5 years with a long-acting formulation of testosterone undecanoate in substitution therapy of hypogonadal men
    Zitzmann, Michael
    Saad, Farid
    Nieschlag, Eberhard
    JOURNAL OF SEX RESEARCH, 2008, 45 (02) : 113 - 113
  • [29] IPASS: DATA FROM AN ONGOING STUDY OF THE TOLERABILITY AND EFFECTIVENESS OF INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF MALE HYPOGONADISM
    Zitzmann, M.
    Lianisch, J. U.
    Martern, A.
    JOURNAL OF MENS HEALTH, 2009, 6 (04) : 400 - 400
  • [30] IPASS: DATA FROM AN ONGOING STUDY OF THE TOLERABILITY AND EFFECTIVENESS OF INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF MALE HYPOGONADISM
    Zitzmann, M.
    Hanisch, J. U.
    Mattern, A.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 97 - 97